Your browser doesn't support javascript.
loading
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers.
Sablerolles, Roos S G; Rietdijk, Wim J R; Goorhuis, Abraham; Postma, Douwe F; Visser, Leo G; Schmitz, Katharina S; Geers, Daryl; Bogers, Susanne; van Haren, Eva; Koopmans, Marion P G; Dalm, Virgil A S H; Kootstra, Neeltje A; Huckriede, Anke L W; Akkerman, Renate; Beukema, Martin; Lafeber, Melvin; van Baarle, Debbie; de Vries, Rory D; van der Kuy, P Hugo M; GeurtsvanKessel, Corine H.
Afiliación
  • Sablerolles RSG; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Rietdijk WJR; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Goorhuis A; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Postma DF; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Visser LG; Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, The Netherlands.
  • Schmitz KS; Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, The Netherlands.
  • Geers D; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Bogers S; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van Haren E; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Koopmans MPG; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Dalm VASH; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Kootstra NA; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Huckriede ALW; Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Akkerman R; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
  • Beukema M; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Lafeber M; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • de Vries RD; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van der Kuy PHM; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • GeurtsvanKessel CH; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Clin Infect Dis ; 76(3): e533-e536, 2023 02 08.
Article en En | MEDLINE | ID: mdl-35723273
ABSTRACT
The emergence of SARS-CoV-2 variants raised questions regarding the durability of immune responses after homologous or heterologous boosters after Ad26.COV2.S-priming. We found that SARS-CoV-2-specific binding antibodies, neutralizing antibodies, and T cells are detectable 5 months after boosting, although waning of antibodies and limited cross-reactivity with Omicron BA.1 was observed.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Ad26COVS1 Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Ad26COVS1 Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos